Stockscreener 앱 받기
1.785
2.46%
-0.045
전일 마감가:
$1.83
열려 있는:
$1.84
하루 거래량:
215.47K
Relative Volume:
0.23
시가총액:
$47.45M
수익:
$155.00K
순이익/손실:
$-30.01M
주가수익비율:
-1.0689
EPS:
-1.67
순현금흐름:
$-11.98M
1주 성능:
-2.99%
1개월 성능:
-14.18%
6개월 성능:
-77.00%
1년 성능:
-70.45%
1일 변동 폭
$1.7517
$1.88
1주일 범위
$1.73
$1.9262
52주 변동 폭
$1.71
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
명칭
Inmune Bio Inc
전화
(858) 964-3720
주소
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
INMB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.785 | 48.65M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.71 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
644.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.68 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
821.33 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.86 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-07-01 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-21 | 개시 | Alliance Global Partners | Buy |
| 2024-09-27 | 개시 | Raymond James | Outperform |
| 2024-08-22 | 개시 | Scotiabank | Sector Outperform |
| 2023-06-01 | 개시 | Robert W. Baird | Outperform |
| 2022-05-24 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | 재확인 | Maxim Group | Buy |
| 2021-04-21 | 개시 | B. Riley Securities | Buy |
| 2021-01-22 | 재확인 | Maxim Group | Buy |
| 2020-09-01 | 개시 | BTIG Research | Buy |
| 2020-07-15 | 재확인 | H.C. Wainwright | Buy |
모두보기
Inmune Bio Inc 주식(INMB)의 최신 뉴스
Is INmune Bio Inc. a candidate for recovery playTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
Sentiment analysis tools applied to INmune Bio Inc.Wall Street Watch & Long-Term Capital Growth Strategies - newser.com
Analyzing recovery setups for INmune Bio Inc. investorsPortfolio Gains Report & Verified Stock Trade Ideas - newser.com
Heatmap analysis for INmune Bio Inc. and competitorsMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com
Does INmune Bio Inc. stock trade at a discount to peersMarket Risk Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Short interest data insights for INmune Bio Inc.Weekly Loss Report & High Conviction Trade Alerts - newser.com
What makes INmune Bio Inc. stock attractive to growth fundsQuarterly Profit Review & Stock Portfolio Risk Control - newser.com
Earnings visualization tools for INmune Bio Inc.Rate Cut & Safe Entry Point Identification - newser.com
Published on: 2025-11-02 21:20:18 - newser.com
Published on: 2025-11-02 20:37:16 - newser.com
Inmune Bio Reports Q3 2025 Financial Results - MSN
How INmune Bio Inc. stock reacts to Fed rate cutsPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
Statistical indicators supporting INmune Bio Inc.’s strengthMarket Activity Summary & Fast Exit/Entry Strategy Plans - newser.com
INmune Bio, Inc. (NASDAQ:INMB) Q3 2025 Earnings Call Transcript - Insider Monkey
Will INmune Bio Inc. stock outperform tech sector in 2025Treasury Yields & Daily Chart Pattern Signal Reports - newser.com
Inmune Bio to Host Q3 Results Conference Call - MSN
What analysts say about INmune Bio Inc stockMarket Liquidity Analysis & High Return Trading Ideas - earlytimes.in
How INmune Bio Inc. stock benefits from global expansionJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com
Candlestick signals on INmune Bio Inc. stock todayWeekly Trading Summary & AI Optimized Trade Strategies - newser.com
Sector ETF performance correlation with INmune Bio Inc.July 2025 Trends & AI Driven Price Forecasts - newser.com
Can volume confirm reversal in INmune Bio Inc.July 2025 Volume & Fast Moving Market Watchlists - newser.com
Earnings call transcript: INmune Bio beats Q3 2025 EPS forecast, stock dips - Investing.com Australia
Earnings call transcript: INmune Bio beats Q3 2025 EPS forecast, stock dips By Investing.com - Investing.com South Africa
Is INmune Bio Inc. stock overvalued by current metricsRisk Management & Daily Growth Stock Tips - newser.com
Inmune Bio outlines 2026 regulatory milestones and cash runway through Q4 2026 - MSN
Is it time to cut losses on INmune Bio Inc.Weekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
Transcript : INmune Bio, Inc., Q3 2025 Earnings Call, Oct 30, 2025 - MarketScreener
INmune Bio Inc (INMB) Q3 2025 Earnings Call Highlights: Regulatory Progress and Financial ... - Yahoo Finance
INmune Bio Inc (INMB) Q3 2025 Earnings Call Highlights: Regulato - GuruFocus
INmune Bio Shrinks Losses While Analysts See Upside Ahead - Finimize
INMB Maintains Strong Cash Position with $27.7 Million on Hand - GuruFocus
INmune Bio Q3 net loss narrows to $6.5 mln, names new CEO - MarketScreener
[8-K] Inmune Bio, Inc. Reports Material Event | INMB SEC FilingForm 8-K - Stock Titan
INmune Bio Inc. (INMB) Q3 FY2025 earnings call transcript - Yahoo Finance
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update - The Manila Times
INmune Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
INMB posts Q3 loss and $16,514,000 impairment amid XPro setback - Stock Titan
Inmune Bio Inc (INMB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
0.05%
자본화:
|
볼륨(24시간):